clinical trial to study the comparative effect of a classical unani antiobesity drug safoof-e-muhazzil on hyperlipidemia in its classical powder form and in compressed tablet form
Phase 2
Completed
- Registration Number
- CTRI/2011/06/001825
- Lead Sponsor
- Department of Moalejat Medicine Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Person aged 20 - 70 Years M/F
Patients willing to sign consent form & participate in Clinical Trial voluntarily.
Hyperlipidemic
Exclusion Criteria
Persons below 20 yrs and Above 70 yrs of age
Pregnancy
Liver diseases
Renal diseases
Diabetes mellitus Type II
Alcoholic
AIDS
Thyroid Disease
Drug intake ? Corticosteroids, Diuretics, Beta-blockers, Oral contraceptives, Cyclosporin, Androgens & Retinoids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method hyperlipidemiaTimepoint: 0,2,4, and 6 weeks
- Secondary Outcome Measures
Name Time Method obesity, hypertensionTimepoint: 0,2,4, and 6 weeks